What is the difference between Ghrelin and Ipamorelin?

Ghrelin: Endogenous 28-amino acid peptide secreted primarily by the stomach that functions as both the primary hunger signal and a potent growth hormone secretagogue. The n-octanoyl modification at Ser-3 (acylated form) is required for GHS-R1a receptor binding and GH-stimulating activity. Understanding ghrelin explains the mechanism behind the entire GHRP class of research peptides. Ipamorelin: Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist. It stimulates GH release with high selectivity — minimal cortisol or prolactin elevation compared to older GHRPs. Widely used in research protocols for body composition, sleep quality, and recovery. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take Ghrelin and Ipamorelin together?

There is no specific, well-documented interaction rule for combining Ghrelin and Ipamorelin in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, Ghrelin or Ipamorelin?

Ghrelin is currently investigational (in trials) and Ipamorelin is investigational (in trials). "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

Ghrelin vs Ipamorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

Ghrelin

Investigational (in trials)

Endogenous 28-amino acid peptide secreted primarily by the stomach that functions as both the primary hunger signal and a potent growth hormone secretagogue. The n-octanoyl modification at Ser-3 (acylated form) is required for GHS-R1a receptor binding and GH-stimulating activity. Understanding ghrelin explains the mechanism behind the entire GHRP class of research peptides.

Full profile

Ipamorelin

Investigational (in trials)

Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist. It stimulates GH release with high selectivity — minimal cortisol or prolactin elevation compared to older GHRPs. Widely used in research protocols for body composition, sleep quality, and recovery.

Full profile

	Ghrelin	Ipamorelin
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	GHRL, growth hormone-releasing peptide endogenous, ghrelinergic peptide, acyl ghrelin	NNC 26-0161, Ipamorelin acetate
Evidence	Investigational (in trials)	Investigational (in trials)
Dosing range	0.5mcg/kg–2mcg/kg mcg/kg, IV or SC bolus; endogenous levels peak pre-meal	100mcg–300mcg mcg, 1–3x daily (typically pre-sleep and/or pre-workout)
Administration	Intravenous (research), Subcutaneous injection	Subcutaneous injection, Intramuscular injection
Key side effects	Appetite stimulation, Transient hyperglycemia, Water retention, GH pulse stimulation	Water retention (mild), Tingling / numbness in extremities, Increased appetite, Headache (transient)
Cited sources	2 references	3 references

Key differences

Administration: Ghrelin — Intravenous (research), Subcutaneous injection; Ipamorelin — Subcutaneous injection, Intramuscular injection.
Dosing units differ: Ghrelin is dosed in mcg/kg, Ipamorelin in mcg — they operate at different scales.
Frequency: Ghrelin is typically IV or SC bolus; endogenous levels peak pre-meal; Ipamorelin is 1–3x daily (typically pre-sleep and/or pre-workout).
Research depth: this profile cites 2 sources for Ghrelin vs 3 for Ipamorelin.

How each works

Ghrelin

Ghrelin was discovered in 1999 as the endogenous ligand for the GHS-R1a receptor. Its acylated form activates GH release from the pituitary, stimulates appetite via NPY/AgRP hypothalamic neurons, and modulates energy homeostasis and fat storage. The des-acyl form (majority of circulating ghrelin) lacks GHS-R1a activity but has independent cardiovascular and cellular effects.

Ipamorelin

Ipamorelin selectively stimulates GH release via the ghrelin receptor (GHS-R1a) without significantly elevating ACTH or cortisol — the feature that distinguishes it from GHRP-6 and GHRP-2 (Raun et al., 1998, in swine/rodent models). Human data are limited: a PK study in 40 volunteers established a ~2-hour half-life (Gobburu et al., 1999), and a Phase 2 trial for postoperative ileus (Beck et al., 2014) failed its primary endpoint. It is not FDA-approved, and claims about body composition or recovery are extrapolated from GH physiology, not human outcome trials.

Read the full Ghrelin profile Read the full Ipamorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.